'Year mortality' diaporamas de présentation

Update in Heart Failure July 12, 2007

Update in Heart Failure July 12, 2007. Eddie Needham, MD, FAAFP Program Director Emory Family Medicine Residency Program. Objectives. Define Heart Failure Know the 5 year mortality rate for heart failure

1.22k views • 97 slides

Endocarditis: A Plague for the 21 st Century?

Mikel D. Smith, MD, FACC, FAHA, FASE Professor of Medicine UK Division of Cardiology Director, UK Echo Lab Gill Heart Institute Cardiovascular Grand Rounds September 24, 2009. Endocarditis: A Plague for the 21 st Century?. Patient: DBH. 42 yo Caucasian male

928 views • 71 slides

Genetics of Colorectal Cancer

2.13k views • 46 slides

Building better clinical trials : A perspective from a cell therapy trialist (and dean)

Building better clinical trials : A perspective from a cell therapy trialist (and dean). PRESENTED BY ROBERT D. SIMARI, M.D. 2 year f/up: 1 cardiac death in BMC group 0 deaths in PL group. JAMA 2013, Circ Res 2018. f/up: 0 deaths in BMC group

453 views • 45 slides

Tehran Heart Center Tehran University of Medical Sciences

PCI VS CABG. M . SALARIFAR , MD. Tehran Heart Center Tehran University of Medical Sciences. PCI VS CABG. From 1987 to 2003 326% increase in PCI Now more than 90% stenting. PCI VS CABG. Factors in patient selection.

798 views • 40 slides

Depression

522 views • 33 slides

PROGNISTICATION:

523 views • 33 slides

Managing the acute coronary syndrome: What is new?

Master Class : Advanced CV Risk management in cardiology June 17-18, 2011, London. Presentation topic. Managing the acute coronary syndrome: What is new?. Slide lecture prepared and held by:. Prof. Adam Timmis Barts and the London School of Medicine and Dentistry

453 views • 32 slides

Avy Violari, Mark Cotton, Di Gibb, Abdel Babiker, Jan Steyn, Patrick Jean-Philippe, James McIntyre

ART initiated before 12 weeks reduces early mortality in young HIV-infected infants: evidence from the C hildren with H IV E arly Anti r etroviral Therapy (CHER) Study. Avy Violari, Mark Cotton, Di Gibb, Abdel Babiker, Jan Steyn, Patrick Jean-Philippe, James McIntyre

509 views • 27 slides

On behalf of the EuroHOPE-team: Terje P. Hagen

The E uroHOPE - project: Comparison of treatment and outcome for AMI and stroke patients in Europe. On behalf of the EuroHOPE-team: Terje P. Hagen Department of Health Management and Health Economics, The Medical Faculty, University of Oslo.

339 views • 19 slides

STREAM - One YEAR Mortality Strategic Reperfusion Early After Myocardial Infarction

STREAM - One YEAR Mortality Strategic Reperfusion Early After Myocardial Infarction. STREAM design. STEMI <3 hrs from onset symptoms, PPCI <60 min not possible, 2 mm ST-elevation in 2 leads. RANDOMIZATION 1:1 by IVRS, OPEN LABEL. Strategy B: primary PCI. Strategy A: pharmaco-invasive.

249 views • 15 slides

GUSTO I 90-93

2.9. 2.8. 2.8. 2.7. 2.7. 2.7. Median Time (hrs) Between Symptom Onset and Treatment. InTIME II 97-99. ASSENT II 97-98. GUSTO III 95-97. GUSTO V 99-01. GUSTO I 90-93. ASSENT 3 00-01. Gibson CM, Circulation 2001;104:2632-2634.

329 views • 14 slides

GUSTO I 90-93

2.9. 2.8. 2.8. 2.7. 2.7. 2.7. Median Time (hrs) Between Symptom Onset and Treatment. InTIME II 97-99. ASSENT II 97-98. GUSTO III 95-97. GUSTO V 99-01. GUSTO I 90-93. ASSENT 3 00-01. Gibson CM, Circulation 2001;104:2632-2634.

332 views • 14 slides

The ACUITY Trial randomized 13,819 patients with moderate and high-risk NSTE-ACS.

Major Bleeding Is Associated With Increased One-Year Mortality and Ischemic Events in Patients With ACS: Results From the ACUITY Trial. Steven V. Manoukian, Frederick Feit, Steven R. Steinhubl, Michele D. Voeltz, George D. Dangas, Ramin Ebrahimi, Roxana Mehran, and Gregg W. Stone

233 views • 13 slides

The ACUITY Trial randomized 13,819 patients with moderate and high-risk NSTE-ACS.

Transfusion is Associated With Increased One-Year Mortality and Ischemic Events in Patients With ACS: Results from the ACUITY Trial. Steven V. Manoukian, Michele D. Voeltz, Frederick Feit, Sunil V. Rao, Steven R. Steinhubl, George D. Dangas, Roxana Mehran, and Gregg W. Stone

259 views • 12 slides

Capillary Lumen

Capillary Lumen. Time is Muscle: Delays in Symptom to Door Time are Associated with Poorer Flow in the Muscle Independent of Flow in Artery. 16% rise in risk of a closed muscle for every hour of delay in STEMI (p=0.0005) CM Gibson, JACC 2004. Swollen / Closed Anterior Myocardium.

243 views • 11 slides